Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Cynata Therapeutics Limited
  6. News
  7. Summary
    CYP   AU000000CYP7

CYNATA THERAPEUTICS LIMITED

(CYP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensus 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Cynata Therapeutics Implements Strategic Manufacturing Deal with Fujifilm Subsidiary

12/29/2021 | 01:15am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
CYNATA THERAPEUTICS LIMITED 12.50% 0.405 Delayed Quote.-33.95%
FUJIFILM HOLDINGS CORPORATION -0.32% 6801 Delayed Quote.-19.97%
All news about CYNATA THERAPEUTICS LIMITED
05/25Cynata Therapeutics Secures US FDA Clearance for Phase 2 Stem Cell Therapy Trial; Share..
MT
04/20Cynata Therapeutics Enrolls First Patients for Phase 1 Diabetic Foot Ulcer Trial; Share..
MT
04/20Cynata Therapeutics Limited Advances Clinical Trial in Diabetic Foot Ulcers
CI
03/07CYNATA THERAPEUTICS : Updated Investor Presentation
PU
02/27Cynata Therapeutics Limited Receives Notice of Decision to Grant A Patent from Chinese ..
CI
02/24Cynata Therapeutics Limited Reports Earnings Results for the Half Year Ended December 3..
CI
01/27Cynata Therapeutics to Secure Japanese Patent for Stem Cell Technology
MT
01/26Cynata Therapeutics Limited Receives Decision to Grant A Patent in Japan
CI
01/18Cynata Therapeutics Secures Tax Rebate for R&D Activities
MT
2021Cynata Therapeutics Implements Strategic Manufacturing Deal with Fujifilm Subsidiary
MT
More news
Financials
Sales 2021 1,55 M 1,09 M 1,09 M
Net income 2021 -7,69 M -5,44 M -5,44 M
Net cash 2021 26,7 M 18,9 M 18,9 M
P/E ratio 2021 -8,57x
Yield 2021 -
Capitalization 58,0 M 41,1 M 41,1 M
EV / Sales 2020 8,24x
EV / Sales 2021 29,5x
Nbr of Employees 2
Free-Float 85,7%
Chart CYNATA THERAPEUTICS LIMITED
Duration : Period :
Cynata Therapeutics Limited Technical Analysis Chart | CYP | AU000000CYP7 | MarketScreener
Technical analysis trends CYNATA THERAPEUTICS LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 0,41 AUD
Average target price 2,00 AUD
Spread / Average Target 394%
Managers and Directors
Ross Alexander MacDonald Chief Executive Officer, MD & Executive Director
Geoff E. D. Brooke Non-Executive Chairman
Jolanta Airey Chief Medical Officer
Kilian Kelly Chief Operating Officer
Paul Kevin Wotton Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
CYNATA THERAPEUTICS LIMITED-33.95%36
GILEAD SCIENCES, INC.-10.47%81 543
REGENERON PHARMACEUTICALS, INC.9.40%74 440
VERTEX PHARMACEUTICALS23.33%69 269
WUXI APPTEC CO., LTD.-22.98%39 423
BIONTECH SE-40.00%37 588